Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “bb-”

4 pharma patents match "bb-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "bb-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “bb-” · 30,257 patents in full index Clear search

  1. US 12187804

    Multivalent and multispecific 41BB-binding proteins

    Inhibrx Biosciences, Inc. · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted

  2. US 10501551

    Multivalent and multispecific 41BB-binding fusion proteins

    Inhibrx, Inc. · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  3. US 6653084

    Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 25, 2003 · Expires Nov 20, 2023

    expired

  4. US 6639060

    erbB-3 nucleic acids

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 28, 2003 · Expires Oct 23, 2023

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.